bioMérieux S.A. provides earnings guidance for the full year 2021. In a persistently uncertain business environment, sales are expected to increase by between 5% and 8% at constant exchange rates and scope of consolidation in 2021. Growth in the first half of 2021 should remain steady, on a par with the trend of Fourth Quarter 2020. 2021 Contributive operating income before non-recurring items should be in line with 2020, at current exchange rates.